Skip to main content
eScholarship
Open Access Publications from the University of California

UCLA

UCLA Previously Published Works bannerUCLA

The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19.

  • Author(s): Cai, Jingjing;
  • Li, Haomiao;
  • Zhang, Changjiang;
  • Chen, Ze;
  • Liu, Hui;
  • Lei, Fang;
  • Qin, Juan-Juan;
  • Liu, Ye-Mao;
  • Zhou, Feng;
  • Song, Xiaohui;
  • Zhou, Jianghua;
  • Zhao, Yan-Ci;
  • Wu, Bin;
  • He, Meiling;
  • Yang, Huilin;
  • Zhu, Lihua;
  • Zhang, Peng;
  • Ji, Yan-Xiao;
  • Zhao, Guang-Nian;
  • Lu, Zhigang;
  • Liu, Liming;
  • Mao, Weiming;
  • Liao, Xiaofeng;
  • Lu, Haofeng;
  • Wang, Daihong;
  • Xia, Xigang;
  • Huang, Xiaodong;
  • Wei, Xiang;
  • Xia, Jiahong;
  • Zhang, Bing-Hong;
  • Yuan, Yufeng;
  • She, Zhi-Gang;
  • Xu, Qingbo;
  • Ma, Xinliang;
  • Wang, Yibin;
  • Yang, Juan;
  • Zhang, Xin;
  • Zhang, Xiao-Jing;
  • Li, Hongliang
  • et al.
Abstract

Corticosteroid therapy is now recommended as a treatment in patients with severe COVID-19. But one key question is how to objectively identify severely ill patients who may benefit from such therapy. Here, we assigned 12,862 COVID-19 cases from 21 hospitals in Hubei Province equally to a training and a validation cohort. We found that a neutrophil-to-lymphocyte ratio (NLR) > 6.11 at admission discriminated a higher risk for mortality. Importantly, however, corticosteroid treatment in such individuals was associated with a lower risk of 60-day all-cause mortality. Conversely, in individuals with an NLR ≤ 6.11 or with type 2 diabetes, corticosteroid treatment was not associated with reduced mortality, but rather increased risks of hyperglycemia and infections. These results show that in the studied cohort corticosteroid treatment is associated with beneficial outcomes in a subset of COVID-19 patients who are non-diabetic and with severe symptoms as defined by NLR.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View